JP Morgan analyst Brian Ossenbeck downgrades TuSimple Hldgs (NASDAQ:TSP) from Overweight to Underweight.
Blue Water Vaccines Announces Signing Of Sponsored Research Agreement With Cincinnati Children’s Hospital Medical Center For S&P Vaccine Platform Development
Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines to address significant global health
